Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interim Results of the Remede d'Or Study: A Multicenter, Single-Blind, Randomized, Controlled Trial to Assess the Safety and Efficacy of an Innovative Topical Formulation of Erythropoietin for Treating Diabetic Foot Ulcers.
Hamed S, Belokopytov M, Ullmann Y, Safadi M, Stark Y, Shoufani A, Akita S, Liu PY, Teot L. Hamed S, et al. Among authors: stark y. Adv Wound Care (New Rochelle). 2019 Oct 1;8(10):514-521. doi: 10.1089/wound.2018.0808. Epub 2019 Aug 21. Adv Wound Care (New Rochelle). 2019. PMID: 31832270 Free PMC article.
Reduction in surgical site infections by localized administration with D-PLEX100 in patients with multiple risk factors undergoing colorectal surgery.
Senagore AJ, Stark Y, Belotserkovsky O, Reichert M, Wasserberg N, Tulchinsky H, Segev L, Zmora O, Kozloski GA, Emanuel N. Senagore AJ, et al. Among authors: stark y. Am J Surg. 2023 Mar;225(3):485-488. doi: 10.1016/j.amjsurg.2022.11.021. Epub 2022 Nov 23. Am J Surg. 2023. PMID: 36567225 Free article. Clinical Trial.
A prospective, randomized assessment of a novel, local antibiotic releasing platform for the prevention of superficial and deep surgical site infections.
Zmora O, Stark Y, Belotserkovsky O, Reichert M, Kozloski GA, Wasserberg N, Tulchinsky H, Segev L, Senagore AJ, Emanuel N. Zmora O, et al. Among authors: stark y. Tech Coloproctol. 2023 Mar;27(3):209-215. doi: 10.1007/s10151-022-02693-y. Epub 2022 Sep 1. Tech Coloproctol. 2023. PMID: 36050560 Free PMC article. Clinical Trial.
Safety and efficacy of first-in-man intrathecal injection of human astrocytes (AstroRx®) in ALS patients: phase I/IIa clinical trial results.
Gotkine M, Caraco Y, Lerner Y, Blotnick S, Wanounou M, Slutsky SG, Chebath J, Kuperstein G, Estrin E, Ben-Hur T, Hasson A, Molakandov K, Sonnenfeld T, Stark Y, Revel A, Revel M, Izrael M. Gotkine M, et al. Among authors: stark y. J Transl Med. 2023 Feb 14;21(1):122. doi: 10.1186/s12967-023-03903-3. J Transl Med. 2023. PMID: 36788520 Free PMC article. Clinical Trial.
Early versus delayed treatment with glatiramer acetate: Analysis of up to 27 years of continuous follow-up in a US open-label extension study.
Ford CC, Cohen JA, Goodman AD, Lindsey JW, Lisak RP, Luzzio C, Pruitt A, Rose J, Rus H, Wolinsky JS, Kadosh SE, Bernstein-Hanlon E, Stark Y, Alexander JK. Ford CC, et al. Among authors: stark y. Mult Scler. 2022 Oct;28(11):1729-1743. doi: 10.1177/13524585221094239. Epub 2022 Jun 29. Mult Scler. 2022. PMID: 35768939 Free PMC article. Clinical Trial.
Long-term efficacy and safety of three times weekly dosing regimen of glatiramer acetate in relapsing multiple sclerosis patients: Seven-year results of the Glatiramer Acetate Low-frequency Administration (GALA) open-label extension study.
Rieckmann P, Zivadinov R, Boyko A, Selmaj K, Alexander JK, Kadosh S, Rubinchick S, Bernstein-Hanlon E, Stark Y, Ashtamker N, Davis MD, Khan O. Rieckmann P, et al. Among authors: stark y. Mult Scler J Exp Transl Clin. 2021 Dec 13;7(4):20552173211061550. doi: 10.1177/20552173211061550. eCollection 2021 Oct. Mult Scler J Exp Transl Clin. 2021. PMID: 34925876 Free PMC article.
Whole Cell Panning with Phage Display.
Stark Y, Venet S, Schmid A. Stark Y, et al. Methods Mol Biol. 2017;1575:67-91. doi: 10.1007/978-1-4939-6857-2_5. Methods Mol Biol. 2017. PMID: 28255875
42 results